Judgment of the Court (First Chamber), 13 March 2014
Octapharma France SAS v Agence nationale de sécurité du médicament et des produits de santé (ANSM) and Ministère des Affaires sociales et de la Santé
Request for a preliminary ruling from the Conseil d’État (France)
Approximation of laws — Directive 2001/83/EC — Directive 2002/98/EC — Scope — Labile blood product — Plasma prepared by means of an industrial process — Simultaneous or exclusive application of the directives — Option for a Member State to provide for a more rigorous regime for plasma than for medicinal products
Case C‑512/12
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Opinion
ECLI:EU:C:2013:727 |
|
|
|
Judgment
ECLI:EU:C:2014:149 |
|
|
|